Huayuan Securities: ConvaTec Group (09926.HK) HARMONi data further updated, maintaining "buy" rating.

Wisdom Financial APP learned that Huayuan Securities released a research report stating that it maintains a "buy" rating on Kangfang Biology (09926.HK), with estimated operating income of 34.19/55.98/85.77 billion yuan for the years 2025-2027. Calculated through the DCF method, assuming a perpetual growth rate of 3% and a WACC of 7.06%, the company's fair equity value is 187.5 billion Hong Kong dollars (exchange rate taken as 1 yuan = 1.07 Hong Kong dollars). Given the company's outstanding innovation pipeline, strong commercialization, and increasing clarity of overseas clinical certainty.